Loading provider…
Loading provider…
Neurology Physician in Nashville, TN
NPI: 1144220450Primary Practice Location
VANDERBILT UNIVERSITY MEDICAL CENTER
2200 Childrens Way, Nashville, TN
Primary Employer
Vanderbilt Medical Group
vanderbilthealth.com
HQ Phone
Get MD Arthur's Phone Numberphone_androidMobile
Get MD Arthur's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNJ State Medical License
TN State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 29 | 44 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 16 | 16 |
| 3 | 95806Unattended sleep study with recording of heart rate, oxygen, respiratory airflow and effort | 15 | 15 |
| 4 | 99213Established patient office or other outpatient visit, typically 15 minutes | 12 | 14 |
| 5 | 99204New patient office or other outpatient visit, 45-59 minutes | 11 | 11 |
Deep brain stimulation improves restless legs syndrome in patients with Parkinson disease.
Authors: Klepitskaya, Olga, Liu, Ying, Sharma, Saloni, Sillau, Stefan H, Tsai, Jean, Walters, Arthur S
Journal: Neurology
Publication Date: 2018-08-15
The Role of BTBD9 in Striatum and Restless Legs Syndrome.
Authors: Lyu, Shangru, Xing, Hong, DeAndrade, Mark P, Liu, Yuning, Perez, Pablo D, Yokoi, Fumiaki, Febo, Marcelo, Walters, Arthur S, Li, Yuqing
Journal: eNeuro
Publication Date: 2019-10-10
Lead Sponsor: XenoPort, Inc.
Intervention / Treatment: DRUG: HORIZANT 600 mg
Lead Sponsor: XenoPort, Inc.
Intervention / Treatment: DRUG: Placebo, DRUG: HORIZANT 600 mg, DRUG: HORIZANT 300 mg
Lead Sponsor: Theresa Zesiewicz, MD
Intervention / Treatment: DRUG: Gabapentin enacarbil extended release, DRUG: Gabapentin immediate release